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Abstract
Background: The genetic engineering of antibiotic-producing
Streptomyces strains is an approach that became a successful
methodology in developing new natural polyketide derivatives.
Glycosyltransferases are important biosynthetic enzymes that link
sugar moieties to aglycones, which often derive from polyketides.
Biological activity is frequently generated along with this process.
Here we report the use of glycosyltransferase genes isolated from
the landomycin biosynthetic gene cluster to create hybrid land-
omycin/urdamycin oligosaccharide antibiotics.
Results : Production of several novel urdamycin derivatives by a
mutant of Streptomyces fradiae Tu«2717 has been achieved in a
combinatorial biosynthetic approach using glycosyltransferase
genes from the landomycin producer Streptomyces cyanogenus
S136. For the generation of gene cassettes useful for combinatorial
biosynthesis experiments new vectors named pMUNI, pMUNII
and pMUNIII were constructed. These vectors facilitate the
construction of gene combinations taking advantage of the
compatible MunI and EcoRI restriction sites.
Conclusions: The high-yielding production of novel oligosac-
charide antibiotics using glycosyltransferase gene cassettes
generated in a very convenient way proves that glycosyltrans-
ferases can be flexible towards the alcohol substrate. In addi-
tion, our results indicate that LanGT1 from S. cyanogenus
S136 is a D-olivosyltransferase, whereas LanGT4 is a L-rhodinosyl-
transferase. ß 2001 Elsevier Science Ltd. All rights reserved.
Keywords: Urdamycin; Landomycin; Glycosyltransferase; Com-
binatorial biosynthesis ; Vector system
1. Introduction
Many biologically active natural compounds are pro-
duced by actinomycetes, most of them by Streptomyces
species. Since the ¢rst report on using genetic engineering
techniques to create hybrid antibiotics the potential of
manipulating biosynthetic pathways in Streptomyces has
received much attention [1,2]. Many naturally occurring
bioactive metabolites possess unusual carbohydrate moi-
eties, which serve as molecular recognition elements im-
portant for biological activities. Without these sugar ele-
ments, the biological activities are often either completely
abolished or dramatically decreased [3,4].
There is an increasing interest in antibiotics contain-
ing oligosaccharide structures. As oligosaccharide anti-
biotics are di⁄cult to produce by chemical synthesis,
the genetic engineering of oligosaccharide structures
could be an important and very promising technique.
Recently it has been shown that glycosyltransferases, re-
sponsible for the formation of oligosaccharide struc-
tures, may have a certain degree of £exibility towards nu-
cleotide sugar donor but also towards the acceptor
molecule [5^7].
Landomycin A, produced by Streptomyces cyanogenus
S136, and urdamycin A, produced by Streptomyces fradiae
1074-5521 / 01 / $ ^ see front matter ß 2001 Elsevier Science Ltd. All rights reserved.
PII: S 1 0 7 4 - 5 5 2 1 ( 0 1 ) 0 0 0 9 1 - 6
1 Also corresponding author.
* Corresponding author.
E-mail addresses: rohrj@musc.edu (J. Rohr),
andreas.bechthold@uni-freiburg.de (A. Bechthold).
CHBIOL 155 12-12-01 Cyaan Magenta Geel Zwart
Chemistry & Biology 8 (2001) 1239^1252
www.elsevier.com/locate/chembiol
Tu«2717, belong to the angucycline group of antibiotics [8].
In various biological tests landomycin A showed interest-
ing antitumor activities, in particular against prostata can-
cer cell lines [9], and it was shown that landomycin A
inhibits DNA synthesis and G1/S cell cycle progression
[10]. In contrast, urdamycin A possesses only weak anti-
tumor activity. One important di¡erence between both
compounds is the oligosaccharide side chain attached to
the polyketide moiety. The hexasaccharide side chain of
landomycin A is comprising two repeating trisaccharides
each consisting of the sequence L-D-olivose-(4C1)-L-D-oli-
vose-(3C1)-K-L-rhodinose (Fig. 1) [11]. The same deoxy-
sugar building blocks are assembled to a trisaccharide
chain in urdamycin A forming the sequence L-D-olivose-
(3C1)-K-L-rhodinose-(4C1)-L-D-olivose [12]. This trisac-
charide is connected to the aglycone by an unusual C-
glycosidic bond and urdamycin A contains an additional
L-rhodinose attached O-glycosidically at the 12b-position
(Fig. 1).
The biosynthetic gene clusters of both compounds have
been cloned and sequenced [6,13^16]. Four glycosyltrans-
ferase genes have been detected in each cluster. The func-
tion of glycosyltransferases involved in urdamycin biosyn-
thesis has been elucidated [15,16] and the generation of a
strain of S. fradiae Tu«2717 with mutations in three of four
glycosyltransferase genes producing monoglycosylated in-
termediates as aquayamycin has been described [16]. Here
we report the successful expression of glycosyltransferase
genes of the landomycin producer in a mutant of the ur-
damycin producer S. fradiae Tu«2717, which led to the
formation of various, new urdamycin derivatives with
new saccharide side chains. We also introduce a novel
cloning vector allowing the simple and convenient set up
of gene cassettes.
Fig. 1. Structures of landomycin A produced by S. cyanogenus S136 and urdamycin derivatives produced by S. fradiae and mutants S. fradiae A-x and
S. fradiae A-0. For the urdamycins only A- and B-type aglycones are shown. These are produced as a complex with C- and D-type urdamycins without
changes in the sugar moieties [21].
CHBIOL 155 12-12-01 Cyaan Magenta Geel Zwart
1240 Chemistry & Biology 8/12 (2001) 1239^1252
2. Results
2.1. Sequence comparison of glycosyltransferases from the
landomycin and urdamycin biosynthetic gene cluster
It has been described that the comparison of the de-
duced products of all eight putative glycosyltransferase
genes from the landomycin and urdamycin biosynthetic
gene cluster with proteins in databases clearly imple-
mented that they are involved in glycosylation steps
[13,15,16]. Since the functions of the glycosyltransferases
UrdGT1a (12b-L-rhodinosyltransferase), UrdGT1b (4A-D-
olivosyltransferase), UrdGT1c (3P-L-rhodinosyltransferase)
and UrdGT2 (9-D-olivosyltransferase) were determined
unambiguously [15,16], we expected to predict the function
of the glycosyltransferases LanGT1, LanGT2, LanGT3
and LanGT4 by sequence comparison. As shown in Fig.
2 the results were: (i) UrdGT2 resembles LanGT2,
(ii) UrdGT1b and UrdGT1c are closely related to
LanGT1 and LanGT3, and (iii) UrdGT1a shows the clos-
est resemblance to LanGT4.
2.2. Generation of a S. fradiae mutant (mutant S. fradiae
A-0) lacking all four glycosyltransferase genes of the
urdamycin biosynthetic gene cluster
S. fradiae BF-1-1 [15] carrying an in-frame deletion in
urdGT2 was used to generate a mutant lacking all four
glycosyltransferase genes from the urdamycin biosynthetic
gene cluster. Mutant BF-1-1 was transformed with pKC-
12-B2 [16], which has been constructed for the deletion of
urdGT1a, urdGT1b and urdGT1c. Apramycin resistant col-
onies were obtained and single cross-over events were con-
¢rmed by hybridization using a ColE1 fragment from
pKC1132 as probe. Integrants were grown without apra-
mycin selection to allow for second cross-over. Apramycin
sensitive clones were screened by PCR for the deletion of a
4 kb BamHI^PstI fragment which removes urdGT1a,
urdGT1b, urdInt and urdGT1c from the chromosome.
The deletion was con¢rmed by Southern hybridization.
Chromosomal DNA from this mutant named S. fradiae
A-0 and DNA from mutant BF-1-1 were isolated and
digested with PstI. Hybridization was carried out using a
5.2 kb SacI fragment as a probe. Strain BF-1-1 showed the
expected bands at 5.2, 2.6 and 2.4 kb whereas mutant A-0
showed one single band at 2.4 kb con¢rming the deletion
(Fig. 3C). Secondary metabolites accumulated by mutant
A-0 were urdamycin I (Fig. 1), urdamycin J (major com-
ponents) and minor amounts of rabelomycin. The geno-
types of all strains used in this study are shown in Fig. 3.
2.3. Construction of a novel vector system allowing a
simple set up of gene cassettes
To facilitate the set up of gene cassettes for combinato-
rial biosynthesis several plasmids named pMUNI, pMU-
NII and pMUNIII were constructed. These vectors con-
tain a single MunI and a single EcoRI restriction site
within the polylinker. Genes can be cloned into these vec-
tors between both restriction sites. As MunI and EcoRI
are compatible, gene cassettes can be generated as depicted
in Fig. 4. Important restriction sites of vectors pMUNI,
pMUNII and pMUNIII are given in Table 1. pMUNI still
retains the intact lacZP from pBluescript allowing blue/
white screening. Gene cassettes generated in one of these
vectors can be restricted by HindIII and XbaI and can be
ligated into the HindIII and XbaI sites of plasmid
pUWL201 [17]. This plasmid contains the minimal repli-
con from pIJ101 [18] and the tsr gene from Streptomyces
azureus conferring resistance to thiostrepton for propaga-
tion and selection in Streptomyces. The ColE1 replicon
and the L-lactamase from pBluescript SK3 are used for
maintenance in Escherichia coli. The strong constitutive
ermE promoter [19] allows the expression of genes in
Streptomyces under control of the constitutive erythromy-
cin resistance promoter.
2.4. Expression of single glycosyltransferase genes in
S. fradiae A-x and S. fradiae A-0
As listed in Table 2 all genes were expressed singly in S.
fradiae A-x and S. fradiae A-0. urdGT2, lanGT1, lanGT2,
lanGT3 and lanGT4 were ampli¢ed by PCR, ¢rst cloned
Fig. 2. Dendrogram derived from the comparison of urdamycin and
landomycin glycosyltransferase sequences (accession numbers: UrdGT1a
AAF00214, UrdGT1b AAF00215, UrdGT1c AAF00217, UrdGT2
AAF00209, LanGT1 AAD13555, LanGT2 AAD13553, LanGT3
AAD13559, LanGT4 AAD13562). The dendrogram was drawn based
on an alignment built with DNASIS using the resettings of the pro-
gram. Genetic similarity is given at points of branching.
Table 1
Important restriction sites located in the polylinker of pMUN vectors
Plasmid Restriction sites
pMUN1 HindIII, MunI, EcoRV, EcoRI, NsiI, BamHI, SpeI, XbaI
pMUN2 HindIII, MunI, NcoI, NsiI, NdeI, BglII, EcoRI, SpeI, XbaI
pMUN3 HindIII, MunI, NcoI, NsiI, NdeI, BglII, EcoRI, BamHI,
SpeI, XbaI
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into the vector pMUNII and then transferred to the ex-
pression vector pUWL201. These constructs as well as
constructs containing urdGT1a, urdGT1b and urdGT1c
[16] were used to transform the A-x and A-0 mutants.
The expected production of compounds 100-1 and 12b-
derhodinosyl-urdamycin G (Fig. 5) was observed when
urdGT1c was expressed in mutant A-x and compound
100-2 (Fig. 5) was found when urdGT1a was expressed.
Also as expected, urdamycinone B and aquayamycin
(Fig. 1) were produced when urdGT2 was expressed in
mutant A-0.
Thin-layer chromatography (TLC) and high-perform-
ance liquid chromatography (HPLC) analysis of culture
supernatants of mutant A-0 containing either lanGT1, or
lanGT2, or lanGT3, or lanGT4 did not show the formation
of any new compound. However, new compounds were
produced by mutant A-x containing either lanGT1 or
lanGT4. 12b-Derhodinosyl-urdamycin G (and various fol-
low-up products including the previously not described
photochemical rearrangement product, named lourdamy-
cin), compound 100-1, and its new 5-hydroxy analog (Fig.
5) were the principal products of mutant A-x after expres-
sion of lanGT4. By experimental incidents we also isolated
one plasmid containing two copies of lanGT4. Expression
of this plasmid, which is a strong overexpression of the
lanGT4 gene, in mutant A-x resulted in 12b-derhodinosyl-
urdamycin G plus large amounts (30% of total produc-
tion) of urdamycin N and traces of the new urdamycin
Q (Fig. 5). Small amounts of novel compounds, presum-
ably ladamycins A2 and B2, were detected when extracts of
S. fradiae A-x containing lanGT1 were carefully analyzed
by HPLC-mass spectrometry (MS).
2.5. Coexpression of urdGT2, urdGT1a, urdGT1b and
urdGT1c in S. fradiae A-0
The successful implementation of the pMUN vectors
requires all genes to be e⁄ciently transcribed from the
erythromycin resistance promoter. As a control, plasmids
pUWL-u1a-u2 containing urdGT1a and urdGT2 and
pUWL-u2-u1a-u1b-u1c containing all four urdamycin gly-
cosyltransferase genes were constructed and expressed in
S. fradiae A-0. Compound 100-2 was identi¢ed when
urdGT1a and urdGT2 were expressed and urdamycin A
production was restored to similar levels as in the wild-
type after coexpression of all four genes (Table 2).
Fig. 3. A: Organization of the urdamycin biosynthetic gene cluster from S. fradiae Tu«2717. Genes and their direction of transcription are indicated by
arrows; active glycosyltransferase genes are shown in red, polyketide synthase genes in blue; the blue bar shows the localization of the fragment used
as probe for hybridization; only relevant restriction sites are shown. B: Genotypes of glycosyltransferase gene mutant strains used in this study; inactive
glycosyltransferase genes are shown in dark gray. C: Southern hybridization con¢rming the deletion in S. fradiae A-0; lane M: DIG-labelled molecular
size marker with the following fragments shown: 1953 bp, 2799 bp, 3639 bp, 4899 bp, 6106 bp; lane 1: chromosomal DNA isolated from S. fradiae
BF-1-1, digested with PstI ; lane 2: chromosomal DNA isolated from S. fradiae A-0, digested with PstI (for details see text).
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2.6. Coexpression of landomycin glycosyltransferase genes
in S. fradiae A-x
The expression of lanGT1 and/or lanGT4 in S. fradiae
A-x resulted in the accumulation of hybrid antibiotics (see
above). Gene cassettes containing lanGT1+either lanGT2,
or lanGT3 or lanGT4 and lanGT4+either lanGT2 or
lanGT3, respectively, were constructed and expressed in
mutant A-x. Analysis of supernatant of the strain contain-
ing lanGT1+lanGT4 showed production of several novel
compounds, namely ladamycin A3, its follow-up product
ladamycin D3 and ladamycin B3 (Fig. 5) at high levels
(90% of total production). These compounds were also
produced by mutants containing lanGT1+lanGT4+
lanGT2, lanGT1+lanGT4+lanGT3, and the one which con-
tained all four landomycin glycosyltransferase genes.
Fig. 4. Generation of a gene cassette containing lanGT1 and lanGT4 using the pMUN vector system.
Table 2
Mutants, glycosyltransferase gene constructs and resulting metabolites
Strain Plasmid Expressed glycosyltransferase Products of the recombinant strain
Wild-type ^ urdamycin A, urdamycin B, 12b-derhodinosyl-urdamycin A
A-0 pUWL201 ^ urdamycin I, urdamycin J, rabelomycin
A-0 pUWL-urdGT2 UrdGT2 aquayamycin, urdamycinone B
A-0 pUWL-u1a-u2 UrdGT1a+UrdGT2 100-2, aquayamycin, urdamycinone B
A-0 pUWL-u2-u1b-u1c-u1a UrdGT2+UrdGT1a+UrdGT1b+UrdGT1c urdamycin A, 12b-derhodinosyl-urdamycin A, urdamycin G, 100-2,
urdamycin B, 100-1
A-x pUWL201 ^ aquayamycin, urdamycinone B
A-x pUWL-I1 LanGt1 aquayamycin, urdamycinone B, ladamycin A2, ladamycin B2
pUWL-I1-I2 LanGT1+LanGT2
pUWL-I1-I3 LanGt1+LanGT3
pUWL-I1-I2-I3 LanGT1+LanGT2+LanGT3
A-x pUWL-I4 LanGT4 12b-derhodinosyl-urdamycin G, aquayamycin, 100-1, urdamycinone B
pUWL-I2-I4 LanGT2+LanGT4
pUWL-I3-I4 LanGT3+LanGT4
pUWL-I2-I3-I4 LanGT2+LanGT3+LanGT4
A-x pUWL-I4-I4 LanGT4+LanGT4 12b-derhodinosyl-urdamycin G, 100-1, urdamycin N
A-x pUWL-I4-I1 LanGT4+LanGT1 ladamycin A3, ladamycin B3
pUWL-I1-I2-I4 LanGT1+LanGT2+LanGT4
pUWL-I1-I3-I4 LanGT1+LanGT3+LanGT4
pUWL-I1-I2-I3-I4 LanGT1+LanGT2+LanGT3+LanGT4
Expression of urdGT1a, urdGT1c and gene cassettes containing various combinations of these genes in mutant A-x and the resulting metabolites have
been described [17]. Expression of single glycosyltransferase genes and gene cassettes of the landomycin cluster in mutant A-0 and expression of lanGT2,
lanGT3 and lanGT2+lanGT3 in mutant A-0 did not result in the production of new metabolites.
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2.7. Structures
All structures, except those for ladamycins A2 and A3
(Fig. 5), were determined using nuclear magnetic reso-
nance (NMR) and MS. Ladamycins A2 and A3 were iden-
ti¢ed through HPLC-MS. In both cases, the HPLC-UV
revealed the same 5-hydroxy-1,4-naphthoquinone chromo-
phore known from aquayamycin and urdamycin A, but a
di¡erent retention time than all known urdamycins. Com-
pared to aquayamycin, the mass of 616 g/mol for ladamy-
cin A2 (in agreement with C31H36O13) indicates an addi-
tional olivose moiety, and the mass of 730 g/mol found for
ladamycin A3 indicates an additional olivose plus an addi-
tional rhodinose moiety. Ladamycin A2 was observed in
S. fradiae A-x containing lanGT1 and ladamycin A3 was
observed in S. fradiae A-x after coexpressing lanGT1 and
lanGT4.
The existence of ladamycin A3 is also con¢rmed indi-
rectly through the structure of ladamycin D3, its urdamy-
cin D-type analog, found in S. fradiae A-x (lanGT1,
lanGT2, lanGT3, lanGT4). The non-enzymatic conversion
of urdamycin A-type into urdamycin D-type molecules
through addition of transaminated tryptophan is well
known [20]. The negative fast atom bombardment
(FAB) mass spectrum con¢rms the molecular formula
C47H51NO16 (885; m/z found 885, 100%, M3) of ladamy-
cin D3. The 1,4-linkage of the two olivose moieties in
ladamycin D3 follows from the 3JCÿH couplings between
1A-H and C-4P and between 4P-H and C-1A, both ob-
served in the HMBC spectrum (Table 7) as well as from
Fig. 5. Compounds produced by expression of glycosyltransferase genes in mutants S. fradiae A-x and S. fradiae A-0.
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the 13C down¢eld shift observed for C-4P (N 88.2, see Table
6).
Ladamycin B2 was discovered in S. fradiae A-x
(lanGT1). Its structure is suggested from signi¢cant sig-
nals, observed in the 1H NMR spectrum, which reveals
two aromatic A^B systems as well as two olivose moieties.
Ladamycin B3, found in S. fradiae A-x following coex-
pression of lanGT1 and lanGT4, is a structural isomer of
urdamycin B [21], as the high-resolved negative FAB-MS
reveals (C37H44O13, HR calculated 696.2782, found
696.2802). It di¡ers from urdamycin B in the sequence
of its saccharide chain, which is K-L-rhodinose-(1C3)-L-
D-olivose-(1C4)-L-D-olivose. This saccharide chain se-
quence follows from the observed long-range couplings
(HMBC, Table 7) and the chemical shifts of the carbon
signals (N 88.6 for C-4P, N 77.3 for C-3A). The 3JCÿH
couplings between 4P-H and C-1A and between 1A-H
and C-4P prove the 1,4-linkage of the two olivose
units, whereas the coupling between 1B-H and C-3A
proves the linkage of the terminal rhodinose to 3-OH of
olivose A.
The major product of S. fradiae A-x containing lanGT4
is 12b-derhodinosyl-urdamycin G. Its MS data (negative
atmospheric pressure chemical ionization (APCI)-MS, m/z
600.2, 8%, M3, m/z 582.3, 100%, M3H2O) con¢rm its
molecular formula of C31H36O12 (calculated 600.2207).
This indicates an additional rhodinose compared to aqua-
yamycin. The NMR data (Table 5 and 6) con¢rm the
presence of a rhodinose moiety, and also its linkage to
the 3P-OH group of the C-glycosidically bound D-olivose
moiety (13C NMR and HMBC data, Tables 6 and 7).
Distinct signals of the rhodinose (sugar A) are for instance
the anomeric proton and carbon (NH 4.96; NC 95.2), which
appear in the 1H NMR spectrum as a broad singlet due to
its K-glycosidic linkage and in the anomeric region below N
100 in the 13C NMR spectrum. Another distinct signal of
the rhodinose is the broad quartet (N 4.18, Table 5) of 5A-
H. The linkage of this rhodinose to the 3P-position (of the
C-glycosidically bound D-olivose) is indicated by the typ-
ical down¢eld shift of this signal in the 13C NMR (N 78.7,
Table 6) and is proven unambiguously by the 3JCÿH cou-
plings between 1A-H and C-3P as well as between 3P-H
and C-1A (both were observed in the HMBC spectrum,
Table 7).
The structure of the new compound 5-hydroxy-100-1,
which was also discovered in S. fradiae A-x containing
lanGT4, was deduced from its high-resolved negative
FAB mass spectrum (the M3H3 was observed, calculated
for C31H33O11 581.2023, found 581.2027) indicating one
oxygen atom more than for the known compound 100-1
[22], and the NMR data (Tables 5^7). The position of the
additional OH group in 5-hydroxy-100-1 follows from the
6-H signal, which appears as singlet (N 7.78) in contrast to
100-1, where this is a doublet of an AB system [22]. That
the OH group is located at 5- and not at 6-position could
be unambiguously clari¢ed through the HMBC spectrum,
in which long-range C^H couplings were observed be-
tween this singlet and C-4a, C-5, C-6a, C-7 and C-12.
Another new compound from the same strain, which
has never been observed previously, is lourdamycin, which
Table 3
Primers used for ampli¢cation of glycosyltransferase genes
Ampli¢ed gene Name Sequence
urdGT2 urdGT2F TGGGCCGAGGCAATTGCATCCGGCACTC
urdGT2R GGTGCCGGATCCGCCCGCCAGCACAAG
lanGT1 lanGT1F TCGGCACAATTGGCAGGAGACGCATATG
lanGT1R CGACTCGTGAGATCTCGCGGTCGGTCA
lanGT2 lanGT2F CACCTCAAGCTTCAATTGCAGCAGGGAGTATCCGTG
lanGT2R CGATGCGAGATATCAGACCAG
lanGT3 lanGT3F GCGTGCCAATTGCCAAGGCATATGATG
lanGT3R GGACCGGCCGAGATCTGACGAGGGG
lanGT4 lanGT4F GAATCCCAATTGGAGAACCATATGCGTG
lanGT4R TCCTGACGGGCGGAGATCTTCGGCGGC
Restriction sites introduced for cloning are underlined.
Table 4
Oligonucleotides used for construction of pMUN vectors
Vector Oligosequences Ligated to Cut with
pMUNI AGCTTCAATTGGATATCGAATTCATGCATG pBluescript HindIII/BamHI
CTAGCATGCATGAATTCGATATCCAATTGA
pMUNII AATTGCCATGGATGCATATGAGATCTGAATTC pMUNI MunI/BamHI
GATCGAATTCAGATCTCATATGCATCCATGGC
pMUNIII AATTGCCATGGATGCATATGAGATCTGAATTCG pMUNI MunI/BamHI
GATCCGAATTCAGATCTCATATGCATCCATGGC
Overhanging compatible ends used for insertion of the oligonucleotide are underlined.
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has a linearly assembled tetracyclic aglycone. This could
be deduced from the NMR data. A photochemical rear-
rangement of aquayamycin into the analogous linearly
assembled tetracene-1,6,12-trione derivative has been de-
scribed by Umezawa et al. [23]. The 1H NMR data of the
aglycone moiety of lourdamycin (that includes the C-gly-
cosidically bound D-olivose) are in agreement with those
described for the rearranged aquayamycin. Thus, it is
likely that lourdamycin derives from 12b-derhodinosyl-ur-
damycin G, presumably because of the in£uence of light
during the fermentation and/or puri¢cation process. The
rearranged aglycone structure follows from the long-range
C^H couplings observed in the HMBC spectrum, in par-
ticular the couplings between 12-H and C-1, C-4a, C-5a
and C-11 (Table 7).
After expression of pUWL-l4-l4 in S. fradiae A-x the
new urdamycin Q was found. Since only about 0.3 mg of
the puri¢ed compound was available for characterization,
only a 1H NMR spectrum in d6-acetone was obtained.
This clearly shows the aromatic (N 7.93 and 8.01) as well
Table 5
1H NMR data of ladamycin B3, ladamycin D3, 5-hydroxy-100-1, 12b-derhodinosyl-urdamycin G and lourdamycin in d6-acetone at 400 MHz
Proton Ladamycin B3 Ladamycin D3 5-Hydroxy-100-1 12b-Derhodinosyl-
urdamycin G
Lourdamycin
2-Heq 2.87 dd (14, 1.5)a 2.81 dd (13, 3)a 2.82 dd (13.5, 1.5) 2.67 dd (12.5, 3) 2.82 dd (16, 2)a
2-Hax 3.08 d (14)b 3.28 d (13) 3.05 d (13.5) 2.97 d (12.5) 2.94 d (16)
3-CH3 1.47 s 1.21 s 1.48 s 1.22 s 1.52 s
4-Heq 3.20 dd (17, 1.5) 1.94^2.12b 3.25 dd (18, 1.5) ca. 2.06b 3.36 dd (18, 2)
4-Hax 3.31 d (17) 1.94^2.12b 2.99 d (18) 2.23 d (15) 3.08 d (18)
5-H 7.73 d (8) 6.09 d (10) ^ 6.44 d (10) ^
6-H 8.30 d (8) 7.00 d (10) 7.78 s 6.81 d (10) ^
7-H ^ ^ ^ ^ 7.91 d (8)
8-H ^ ^ ^ ^ 8.00 d (8)
10-H 7.92 d (8) 8.15 s 7.88 d (8) 7.88 d (8) ^
11-H 7.60 d (8) ^ 7.56 d (8) 7.54 d (8) ^
12-H ^ ^ ^ ^ 8.36 s
5Q-H ^ 8.01 s ^ ^ ^
7Q-H ^ 7.58 d (7.5)d ^ ^ ^
8Q-H ^ 7.23 dd (7.5, 7) ^ ^ ^
9Q-H ^ 7.15 dd (7.5, 7) ^ ^ ^
10Q-H ^ 7.57 d (7.5)d ^ ^ ^
1P-H 4.90 dd (11, 2) 4.74 d (10) 4.87 dd (11, 1.5) 4.85 dd (11, 1.5) 4.92 dd (11.5, 2)
2P-Heq 2.46 ddd (13, 5, 2) 2.44 ddd (13, 5, 1.5) 2.51 ddd (13, 5, 2) 2.49 ddd (13, 5, 2) 2.57 ddd (13, 5, 2)
2P-Hax 1.30^1.38b;c 1.16^1.26b;c 1.26^1.43b;c 1.26^1.44b;c 1.26^1.43b;c
3P-H 3.74 ddd (11, 9, 5) 3.68 ddd (11, 9, 5)b 3.78 ddd (11, 9, 5) 3.77 ddd (11, 8.5,5) 3.81 ddd (11, 9, 5)
4P-H 3.14 dd (9, 9) 2.90 dd (9, 9)a 3.15 dd (9, 9) 3.14 dd (9, 9) 3.17 ddd (9, 9, 3)
5P-H 3.55 dq (9, 6)b 3.44 dq (9, 6)b 3.48 dq (9, 6) 3.48 dq (9, 6) 3.51 dq (9, 6)b
6P-CH3 1.35 d (6) 1.05 d (6) 1.35 d (6) 1.35 d (6) 1.37 d (6)
1A-H 4.74 dd (10, 2) 4.61 dd (10, 1.5) 4.98 br s 4.96 br s 4.99 br s
2A-Heq 2.41 ddd (13, 5, 2) 2.33 ddd (12.5, 5, 1.5) 1.26^1.43b;c 1.26^1.44b;c 1.26^1.43b;c
2A-Hax 1.40^1.54b;c 1.39^1.45b;c 1.98^2.09b;c 2.02^2.09b;c 2.02^2.09b;c
3A-Heq ^ ^ 1.98^2.09b;c 2.02^2.09b;c 2.02^2.09b;c
3A-Hax 3.67 ddd (12, 9, 5) 3.61 ddd (11.5, 9, 5)b 1.58^1.64c 1.59^1.64c 1.59^1.64c
4A-H 3.09 ddd (9, 9, 2.5)b 3.05 ddd (9, 9, 3) 3.53 br s 3.54 br s 3.55 br sb
5A-H 3.43 dq (9, 6) 3.37 dq (9, 6)b 4.19 dq (6.5, 1) 4.18 dq (6.5, 1) 4.20 dq (6.5, 1)
6A-CH3 1.30 d (6) 1.26 d (6) 1.14 d (6.5) 1.14 d (6.5) 1.15 d (6.5)
1B-H 4.95 br s 4.91 br s ^ ^ ^
2B-Heq 1.40^1.54b;c 1.39^1.45b;c ^ ^ ^
2B-Hax 2.00^2.10b;c 1.94^2.12b;c ^ ^ ^
3B-Heq 2.00^2.10b;c 1.94^2.12b;c ^ ^ ^
3B-Hax 1.59^1.66c 1.58^1.65c ^ ^ ^
4B-H 3.54 br s 3.53 br s ^ ^ ^
5B-H 4.17 dq (6.5, 1) 4.15 dq (6.5, 1) ^ ^ ^
6B-CH3 1.12 d (6.5) 1.10 d (6.5) ^ ^ ^
OH signalse 4.66 d (2.5), 4.52, 4.17 5.25, 4.90, 4.72, 4.64 d (3), 4.45,
3.12
4.64 12.33, 5.24, 4.74, 4.63,
4.61
13.10, 13.12, 4.64 d (3),
4.14
N in ppm, (J in Hz). Coupling partners con¢rmed by gCOSY experiments.
aObscured by water, visible after addition of D2O.
bObscured by solvent or other signal(s).
cComplex.
dAssignments are interchangeable ; br = broad signal.
eNot all OH signals were observed due to water in the samples.
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as the ole¢nic AB system (N 6.42 and 6.81), characteristic
for the aquayamycin aglycone, and signals for three sug-
ars. The C-glycosidically bound D-olivose (e.g. N 4.94, d,
J = 10 Hz, 1P-H; N 4.01, m, 3P-H), and the two rhodinose
moieties are identi¢ed by typical signals (e.g. N 5.0 s and
5.19 s, 1A-H and 1B-H; N 4.23 q and 4.38 q, 5A-H and
5B-H) in comparison with the known urdamycin O [6].
The data also reveal that urdamycin Q lacks the L-rhodi-
nose at C-12-O, which occurs in urdamycin O, and which
can easily be identi¢ed through its typical 1H signals [6].
The spectroscopic data (NMR, MS), Rf values and
HPLC retention times of all known urdamycin derivatives,
such as 100-1 (found in S. fradiae A-x after expression of
lanGT4), and of urdamycin N (found in S. fradiae A-x
with twice lanGT4) were identical with those previously
described.
Table 6
13C NMR data (from HMBC and HSQC spectra) of ladamycin B3, ladamycin D3, 5-hydroxy-100-1, 12b-derhodinosyl-urdamycin G and lourdamycin in
d6-acetone (100.6 MHz)
Carbon Ladamycin B3 Ladamycin D3 5-Hydroxy-100-1 12b-Derhodinosyl-urdamycin G Lourdamycin
1 196.2 s 206.6 s 196.5 s 205.2 s 195.8 s
2 53.3 t 52.0 t 53.1 t 51.9 t 51.2 t
3 71.8 s 75.3 s 71.6 s 76.6 s 70.3 s
3-CH3 29.5 q 29.4 q 29.8 q 29.5 q 29.4 q
4 43.9 t 43.9 t 37.8 t 43.6 t 36.6 t
4a 149.4 s 80.5 s 137.1 s 81.0 s 138.8 s
5 134.2 d 137.2 d 160.6 s 145.7 d 161.5 s
5a ^ ^ ^ ^ 117.3 s
6 128.8 d 118.3 d 112.4 d 116.8 d 188.4 s
6a 133.5 s 123.4 s 134.7 s 138.5 s 132.1 s
7 188.4 s 155.7 s 188.9 s 189.2 s 119.4 d
7a 115.1 s n.o. 115.2 s 114.3 s ^
8 158.0 s 186.8 s 157.9 s 157.6 s 133.6 d
9 136.9 s 142.8 s 136.4 s 138.2 s 139.2 s
10 133.6 d 135.2 d 133.5 d 133.4 d 159.0 s
10a ^ ^ ^ ^ 115.8 s
11 118.7 d n.o. 118.4 d 118.9 d 188.2 s
11a 134.5 s 116.5 s 134.6 s 131.0 s n.o.
12 182.7 s n.o. 181.2 s 182.3 s 115.7 d
12a 136.3 s 128.4 s 127.1 s 139.5 s 138.5 s
12b 136.4 s 78.1 s 139.0 s 76.9 s ^
2Q ^ n.o. ^ ^ ^
3Q ^ 127.2 s ^ ^ ^
4Q ^ 108.2 s ^ ^ ^
5Q ^ 131.9 d ^ ^ ^
6aQ ^ 136.6 s ^ ^ ^
7Q ^ 112.3 d ^ ^ ^
8Q ^ 122.8 d ^ ^ ^
9Q ^ 121.1 d ^ ^ ^
10Q ^ 120.4 d ^ ^ ^
10aQ ^ 127.2 s ^ ^ ^
1P 71.0 d 70.7 d 71.0 d 71.0 d 71.1 d
2P 39.1 t 39.2 t 37.2 t 37.0 t 36.9 t
3P 70.6 d 70.4 d 78.9 d 78.7 d 78.7 d
4P 88.6 d 88.2 d 75.9 d 75.8 d 75.8 d
5P 74.6 d 74.3 d 76.3 d 76.4 d 76.3 d
6P 17.5 q 17.3 q 17.9 q 17.9 q 17.9 q
1A 101.0 d 100.8 d 95.3 d 95.2 d 95.3 d
2A 36.5 t 36.4 t 23.9 t 23.8 t 23.8 t
3A 77.3 d 76.6 d 25.6 t 25.5 t 25.5 t
4A 75.2 d 74.9 d 66.4 d 66.3 d 66.4 d
5A 72.3 d 72.2 d 67.1 d 67.2 d 67.1 d
6A 17.4 q 17.4 q 16.6 q 16.7 q 16.6 q
1B 95.4 d 95.1 d ^ ^ ^
2B 23.9 t 23.9 t ^ ^ ^
3B 25.4 t 25.5 t ^ ^ ^
4B 66.4 d 66.3 d ^ ^ ^
5B 67.2 d 67.1 d ^ ^ ^
6B 16.7 q 16.5 q ^ ^ ^
N in ppm, 13C multiplicities from gHSQC and gHMBC experiments. n.o. = not observed.
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3. Discussion
Many antibiotics have their aglycone moieties as-
sembled ¢rst followed by decoration with sugar moieties
to produce the ¢nal bioactive compound. In recent years
several glycosyltransferase genes have been isolated from
antibiotic-producing organisms. Among these glycosyl-
transferase genes are lanGT1, lanGT2, lanGT3 and lanGT4
of the landomycin cluster [13], urdGT1a, urdGT1b,
urdGT1c and urdGT2 of the urdamycin cluster [15,16],
those for erythromycin [24,25], megalomicin [26], mithra-
mycin [27,28], elloramycin [29] and oleandomycin biosyn-
thesis [30], graORF14 of the granaticin cluster [31,32] and
dnrS/dnmS of the daunorubicin biosynthetic pathway
[33,34]. Functions of some of these genes have been deter-
mined mostly by gene inactivation experiments [15,16,
24,25,33] and in a few cases by heterologous expression
[26,29,35]. Based on sequence comparison of the deduced
amino acid sequences of the landomycin glycosyltransfer-
ase genes with the closely related urdamycin glycosyltrans-
ferase genes, whose functions were known, some initial
hypothesis could be raised. We expected LanGT1 and
LanGT3 to be involved in the elongation of the hexasac-
charide chain, LanGT2 to be responsible for the attach-
ment of a D-olivose to the polyketide moiety, and LanGT4
to be a rhodinosyltransferase. Recently, the knowledge on
glycosyltransferase genes and other sugar biosynthetic
genes has been exploited for the production of novel gly-
cosylated hybrid antibiotics. Systems constructed by di¡er-
ent groups rely on feeding of aglycones to a modi¢ed host,
which harbors suitable glycosyltransferase and sugar bio-
synthetic genes [36,37]. Liu and coworkers produced sev-
eral new derivatives of methymycin/pikromycin by delet-
ing endogenous sugar biosynthetic genes [7,38] and
coexpression of the calH gene from the calicheamine path-
way [39]. Two recent examples describe the coexpression
of sugar and aglycone biosynthetic genes to generate novel
glycosylated anthracyclines or macrolides, respectively
[40,41].
Some £exibility of glycosyltransferases especially to-
wards their sugar co-substrates has been described making
these glycosyltransferases attractive tools for combinatori-
al biosynthesis. Only a low number of pharmaceutically
important drugs are containing two, three or even more
deoxysugars. The chemical synthesis of such compounds is
very di⁄cult to proceed and therefore impractical, and
nearly impossible to be established in large scale. With
glycosyltransferase genes of the landomycin and urdamy-
cin clusters in hand we wanted to explore whether land-
omycin/urdamycin hybrids carrying modi¢ed sugar side
chains could be generated by expressing glycosyltransfer-
ase gene cassettes.
In addition to mutant S. fradiae A-x, in which three
of four urdamycin glycosyltransferases had been deleted,
we generated a second host (mutant S. fradiae A-0) carry-
ing no functional glycosyltransferase gene. Since both mu-
tants are still capable to produce dTDP-D-olivose and
dTDP-L-rhodinose, which are likely to serve as co-sub-
strates of the landomycin glycosyltransferases, both hosts
were therefore suitable for the heterologous expression of
these genes.
New cloning vectors (pMUNI, pMUNII and pMU-
NIII) were generated based on the compatibility of the
restriction sites EcoRI and MunI. A major advantage of
these vectors is that once a number of biosynthetic genes
cloned in either pMUNI, pMUNII or pMUNIII are avail-
able, they can be rapidly combined to generate large gene
cassettes. Glycosyltransferase genes of the urdamycin clus-
ter were used to test this gene cassette approach. S. fradiae
A-0 containing a plasmid with urdGT1a, urdGT1b,
urdGT1c and urdGT2 was capable to produce urdamycin
A in the same amount as the wild-type supporting the use
of the pMUN vector strategy for combinatorial biosynthe-
sis.
Based on this system we tested the possibility of pro-
ducing novel oligosaccharide antibiotics by expressing
landomycin glycosyltransferase genes in mutants A-x and
A-0. None of the glycosyltransferases was accepting prod-
ucts of mutant A-0 as substrate, which indicates a high
speci¢city of the glycosyltransferase responsible for the
attachment of the ¢rst D-olivose to the aglycone. In con-
trast, aquayamycin and urdamycinone B, the main prod-
ucts of mutant A-x, were accepted as substrates by both
LanGT1 and LanGT4. Expression of these genes, alone or
in combination, resulted in the accumulation of 12b-der-
hodinosyl-urdamycin G and other novel compounds, such
as urdamycin Q, ladamycin B2, ladamycins A3 and D3.
Expression of lanGT3 and lanGT2 or coexpression with
lanGT1 and/or lanGT4 in our hosts did not lead to the
production of new compounds with longer saccharide
chains. Either these enzymes are more speci¢c towards
their alcohol substrates than LanGT1 or LanGT4 and
we were not able to provide a suitable substrate yet, or
the export system of S. fradiae limits the secretion of com-
pounds containing more than three sugars in the 9-side
chain.
The expression of lanGT1 alone or together with lanGT4
resulted in the formation of novel hybrid compounds.
These compounds contain two 1,4-connected D-olivose
units, as known from the landomycin hexasaccharide.
Thus, these compounds combine structural elements of
both landomycins and urdamycins and were therefore des-
ignated ladamycins. The lower production level of lada-
mycin A2 compared to ladamycin A3 might be attributed
to a slow glycosylation rate of aquayamycin by LanGT1,
while the second glycosylation step, the attachment of the
L-rhodinose, occurs faster. Although ladamycins A2 and
A3 were only recognized through HPLC-MS, su⁄cient
NMR data exist for ladamycins B3 and D3, the latter
being a follow-up product of ladamycin A3. These NMR
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data (HMBC, 13C chemical shifts) clearly reveal the 1,4-
linkage of the two D-olivose building blocks.
From these results we conclude that LanGT1 is a D-
olivosyltransferase, which links a second D-olivose to the
4-OH group of another D-olivose, whereas LanGT4 is an
L-rhodinosyltransferase, which attaches an L-rhodinose to
the 3-OH group of a D-olivose. These functions are con-
sistent with the prediction from the sequence comparison
of the landomycin with the urdamycin glycosyltransferases
and their proposed involvement in the hexasaccharide bio-
synthesis of landomycin. Especially LanGT4 displayed re-
laxed substrate speci¢city and was able to glycosylate var-
ious alcohol substrates at reasonable rates, showing the
potential of glycosyltransferases to design and create new
oligosaccharide structures.
4. Signi¢cance
Glycosyltransfer is an important step in the biosynthesis
of antibiotics and is often needed to confer biological ac-
tivity to a compound. We used two glycosyltransferase
gene mutant strains derived from the urdamycin producer
S. fradiae Tu«2717 as hosts to analyze the expression of
glycosyltransferase genes from the landomycin biosyn-
thetic gene cluster of S. cyanogenus S136. A versatile
new cloning system was implemented to facilitate the
construction of gene cassettes. The production of several
novel metabolites at high e⁄ciency proves again that gly-
cosyltransferases are useful tools in combinatorial biosyn-
thesis due to their substrate £exibility. As shown by the
production of ladamycin B3 this technique is not restricted
Table 7
HMBC correlations of ladamycin B3, ladamycin D3, 5-hydroxy-100-1, 12b-derhodinosyl-urdamycin G and lourdamycin
Position Ladamycin B3 Ladamycin D3 5-Hydroxy-100-1 12b-Derhodinosyl-urdamycin G Lourdamycin
2-Heq 1, 2, 4 1, 3, 4, 12b 1, 3, 3-CH3, 4, 12b 1, 3, 4 1, 3, 4
2-Hax 1, 3 1, 3 1, 3, 3-CH3 1, 3, 3-CH3 1, 3
3-CH3 2, 3, 4 1, 2, 3, 4 1, 2, 3, 4 1, 2, 3, 4 2, 3, 4
4-Heq 2, 3, 4a, 5, 12b ^ 2, 3, 3-CH3, 4a, 5, 12b 2, 3, 3-CH3, 4a 2, 3, 4a, 5
4-Hax 3, 4a, 12b ^ 3, 3-CH3, 4a, 5, 12b 3, 3-CH3, 4a 4a, 5
5-H 4, 6a, 12b 6a, 12b ^ 6a, 12b ^
5-OH ^ ^ ^ ^ 4a, 5, 5a
6-H 4a, 7, 12a 4a, 7, 12a 4a, 5, 6a, 7, 12a 4a, 7, 12a ^
7-H ^ ^ ^ ^ 6, 9, 10a
8-H ^ ^ ^ ^ 1P, 6a, 10,
10-H 1P, 8, 11a 1P, 8, 9, 11a, 3Q 1P, 8, 11a 1P, 8, 11a ^
10-OH ^ ^ ^ ^ 9, 10, 10a
11-H 7a, 9, 12 ^ 7a, 9, 12 7a, 9, 12 ^
12-H ^ ^ ^ ^ 1, 4a, 5a, 11
5Q-H ^ 3Q, 4Q, 6aQ, 10aQ ^ ^ ^
7Q-H ^ 10aQ, 9Q ^ ^ ^
8Q-H ^ 6aQ, 10Q ^ ^ ^
9Q-H ^ 7Q, 10aQ ^ ^ ^
10Q-H ^ 6aQ, 8Q, 4Q ^ ^ ^
1P-H 8, 9, 10 9 9, 10 8, 9, 10, 2P, 3P, 5P 8, 9
2P-Heq 3P, 4P 3P, 4P 3P, 4P 3P, 4P 3P, 4P
2P-Hax ^ ^ 9, 1P 9, 1P, 3P, 1P
3P-H ^ ^ ^ 1A, 4P ^
4P-H 1A, 3P, 5P, 6P 1A, 3P, 5P, 6P 3P, 5P, 6P 3P, 5P, 6P ^
5P-H ^ ^ ^ ^ ^
6P-CH3 3P, 4P, 5P 4P, 5P 3P, 5P 4P, 5P 3P, 4P, 5P
1A-H 4P 4P 3P, 3A, 5A 3P, 3A, 5A 5A
2A-Heq 1A, 3A, 4A 1A, 3A, 4A 1A, 4A ^ ^
2A-Hax 1A, 3A 1A, 3A ^ ^ ^
3A-Heq ^ ^ ^ ^ ^
3A-Hax ^ ^ ^ 1A ^
4A-H 3A 3A, 5A, 6A 4A, 6A ^ ^
5A-H ^ ^ ^ 1A, 4A, 6A ^
6A-CH3 4A, 5A 4A, 5A 4A, 5A 4A, 5A 4A, 5A
1B-H 3A, 3B, 5B 3A, 5B ^ ^ ^
2B-Heq ^ ^ ^ ^ ^
2B-Hax ^ ^ ^ ^ ^
3B-Heq ^ ^ ^ ^ ^
3B-Hax ^ ^ ^ ^ ^
4B-H ^ ^ ^ ^ ^
5B-H 4B, 6B 4B, 6B ^ ^ ^
6B-CH3 4B, 5B 4B, 5B ^ ^ ^
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to the addition of single sugar moieties but can be used to
design and generate larger deoxysugar moieties. Combined
with the recently gained knowledge on deoxysugar biosyn-
thetic genes, this will further extend the possibilities of
combinatorial biosynthesis.
5. Materials and methods
5.1. Bacterial strains and culture conditions
S. fradiae Tu«2717 was obtained from the Department of Mi-
crobiology, University of Tu«bingen [12], Germany, S. fradiae BF-
1-1 was obtained from B. Faust, Pharmaceutical Biology, Uni-
versity of Tu«bingen, Germany [15]. Conditions of growth were as
described [16]. E. coli XL1 blue MRFP from Stratagene was used
as host for plasmid propagation. Prior to transformation of
S. fradiae plasmids were passed through E. coli ET12567 (dam-,
dcm-, hsds-, Cm+) to generate demethylated DNA [42].
5.2. General genetic manipulation, DNA sequencing/sequence
analysis and PCR
Routine methods were performed as described [43]. Transfor-
mation of S. fradiae strains was performed according to standard
procedures [44]. Southern hybridization, sequencing and enzy-
matic manipulation of DNA were carried out according to
manufacturer’s directions (Amersham-Pharmacia Biotech, Roche
Diagnostics, Stratagene, Promega). Oligonucleotide primers were
purchased from Amersham-Pharmacia Biotech. PCR was per-
formed using a GeneAmp PCR System 2400 (Applied Biosys-
tems) with similar conditions as described [16]. For ampli¢cation
of the di¡erent glycosyltransferase genes together with their own
ribosomal binding site suitable cosmids or plasmids from the
urdamycin or landomycin gene clusters were used as templates.
Primer sequences are given in Table 3. The ampli¢ed fragments
were cloned into pMUNII except for lanGT2, which was cloned
into pMUNI. Nucleotide sequences were determined by the di-
deoxy chain-termination method using automatic laser £uores-
cence sequencers (Vistra 725, Amersham-Pharmacia Biotech). Se-
quencing reactions were done using a thermosequenase cycle
sequencing kit with 7-deaza-dGTP (Amersham-Pharmacia Bio-
tech) and standard primers (M13 universal and reverse, T3,
T7). Computer-aided sequence analysis was done with the DNA-
SIS software package (version 2.1, 1995; Hitachi Software Engi-
neering), database searches were performed with the BLAST 2.0
program [45] on the server of the National Center for Biotech-
nology Information, Bethesda, MD, USA.
5.3. Construction of pMUN vectors
pBluescript SK3 obtained from Stratagene was used for the
construction of pMUNI. Introduction of new restriction sites into
the multiple cloning site was performed by ligating double-
stranded oligonucleotides into suitable cut plasmids (Table 4).
Double-stranded oligonucleotides were obtained by annealing
two complementary single-stranded oligonucleotides. For this
purpose the two single-stranded oligonucleotides were denatured
by heating (98‡C, 10 min) and then gradually cooled down to
45‡C (non-linear, 30 min). To obtain an overhang for ligating to
the appropriately cut plasmid, the single-stranded oligonucleo-
tides were extended at the 5P-end. The sequence of new plasmids
was con¢rmed by sequencing. For the construction of pMUNI
restriction sites BamHI, SmaI, PstI, EcoRI, EcoRV and HindIII
in pBluescript were replaced by BamHI, NsiI, EcoRI, EcoRV,
MunI and HindIII. For the generation of pMUNII the BamHI,
NsiI, EcoRI, EcoRV and MunI sites of pMUNI were exchanged
for EcoRI, BglII, NdeI, NsiI, NcoI and MunI while deleting the
BamHI site. pMUNIII is similar to pMUNII but retains the
BamHI site from pMUNI (Table 1).
5.4. Plasmids
The bifunctional plasmid pUWL201 [17] was a kind gift of U.
Wehmeier and W. Piepersberg, University of Wuppertal, Ger-
many, and used for expression of single genes and gene cassettes
in S. fradiae. The construction of the gene inactivation plasmid
pKC-12-B2 and of plasmids pMUNurdGT1a, pMUNurdGT1b
and pMUNurdGT1c has been described [16].
5.5. Production, puri¢cation, structure elucidation and chemical
analysis of urdamycins and novel hybrid compounds
Production, puri¢cation, TLC conditions, and HPLC-UV/Vis
conditions for urdamycin derivatives were essentially as described
previously [16]. For HPLC-electrospray ionization (ESI)-MS
analysis separation was performed on an HP1110 (Hewlett-Pack-
ard) with a HP-ODS-Hypersil (100U2.1 mm; 5 Wm) at a £ow
rate of 0.1 ml/min, detection at 250 nm and the following gra-
dient: 0^5 min 20% B, 5^50 min linear to 55% B, 50^60 min
linear to 90% B (solvent A: 90% H2O, 9.95% acetonitrile,
0.05% acetic acid; solvent B: 90% acetonitrile, 9.95% H2O,
0.05% acetic acid). Mass spectra were recorded on a Bruker Es-
quire LC 1.6n mass spectrometer (Bruker Daltronik) equipped
with an electrospray ion source (positive ion mode) (ESI) at a
scan range of 50^1200 m/z with nominal mass resolution.
The structures of ladamycins B2, B3, D3, 5-hydroxy-100-1, ur-
damycin Q and the rearranged lourdamycin were identi¢ed
mainly by NMR spectroscopy, all these structures were also sup-
ported by MS. The instrumentation used was essentially the same
as described previously [6,46], except the Varian NMR instru-
ment, which was recently upgraded into an INOVA 400. For
details, see text and Tables 5^7. The FAB mass spectra and the
high resolutions were recorded at the University of South Caro-
lina Department of Biochemistry and Chemistry facilities in Co-
lumbia, SC, USA, using a VG70SQ double focussing magnetic
sector MS instrument. The APCI mass spectra were recorded at
the Medical University of South Carolina regional mass spectros-
copy center using a Finnigan MAT LCQ.
The structures of ladamycins A2 and A3 were determined by
HPLC-MS (see text).
The known urdamycins mentioned here were identi¢ed by com-
parison with authentic samples using TLC, HPLC-UV/Vis,
HPLC-MS and 1H NMR.
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